XML 58 R6.htm IDEA: XBRL DOCUMENT v3.19.3
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock Issued
Common Stock in Treasury
Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Balance (in shares) at Dec. 31, 2017   23,760 (9,703)      
Balance at Dec. 31, 2017 $ 253,549 $ 238 $ (262,065) $ 265,195 $ (16,599) $ 266,780
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (587)         (587)
Currency translation adjustment 3,646       3,646  
Shares issued for employee benefit plan and compensation (in shares)   42        
Shares issued for employee benefit plan and compensation 336 $ 0   336    
Purchase of treasury shares (in shares)     (13)      
Purchase of treasury shares (615)   $ (615)      
Stock options exercised (in shares)   20        
Stock options exercised 439 $ 0   439    
Shares issued to directors (in shares)   8        
Shares issued to directors 0 $ 0   0    
Employee and director stock-based compensation 2,204     2,204    
Performance - based common stock warrants 471     471    
Balance (in shares) at Mar. 31, 2018   23,830 (9,716)      
Balance at Mar. 31, 2018 263,527 $ 238 $ (262,680) 268,645 (12,953) 270,277
Balance (in shares) at Dec. 31, 2017   23,760 (9,703)      
Balance at Dec. 31, 2017 253,549 $ 238 $ (262,065) 265,195 (16,599) 266,780
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 23,031          
Currency translation adjustment $ (5,190)          
Purchase of treasury shares (in shares) (373)          
Purchase of treasury shares $ (12,564)          
Balance (in shares) at Sep. 30, 2018   23,892 (10,076)      
Balance at Sep. 30, 2018 272,209 $ 239 $ (274,629) 274,493 (21,789) 293,895
Balance (in shares) at Mar. 31, 2018   23,830 (9,716)      
Balance at Mar. 31, 2018 263,527 $ 238 $ (262,680) 268,645 (12,953) 270,277
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 22,659         22,659
Currency translation adjustment (5,058)       (5,058)  
Shares issued for employee benefit plan and compensation (in shares)   14        
Shares issued for employee benefit plan and compensation 254 $ 1   253    
Purchase of treasury shares (in shares)     (212)      
Purchase of treasury shares (6,499)   $ (6,499)      
Stock options exercised (in shares)   10        
Stock options exercised 265 $ 0   265    
Shares issued to directors (in shares)   8        
Shares issued to directors 0 $ 0   0    
Employee and director stock-based compensation 2,465     2,465    
Performance - based common stock warrants (128)     (128)    
Balance (in shares) at Jun. 30, 2018   23,862 (9,928)      
Balance at Jun. 30, 2018 277,485 $ 239 $ (269,179) 271,500 (18,011) 292,936
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 959         959
Currency translation adjustment (3,778)       (3,778)  
Shares issued for employee benefit plan and compensation (in shares)   18        
Shares issued for employee benefit plan and compensation 290 $ 0   290    
Purchase of treasury shares (in shares)     (148)      
Purchase of treasury shares (5,450)   $ (5,450)      
Stock options exercised (in shares)   5        
Stock options exercised 160 $ 0   160    
Shares issued to directors (in shares)   7        
Shares issued to directors 0 $ 0        
Employee and director stock-based compensation 2,139     2,139    
Performance - based common stock warrants 404     404    
Balance (in shares) at Sep. 30, 2018   23,892 (10,076)      
Balance at Sep. 30, 2018 272,209 $ 239 $ (274,629) 274,493 (21,789) 293,895
Balance (in shares) at Dec. 31, 2018   23,933 (10,116)      
Balance at Dec. 31, 2018 262,960 $ 239 $ (275,889) 276,103 (20,281) 282,788
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (1,005)         (1,005)
Currency translation adjustment 1,733       1,733  
Shares issued for employee benefit plan and compensation (in shares)   78        
Shares issued for employee benefit plan and compensation 347 $ 1   346    
Purchase of treasury shares (in shares)     (43)      
Purchase of treasury shares (1,215)   $ (1,215)      
Shares issued to directors (in shares)   8        
Shares issued to directors 0 $ 0   0    
Employee and director stock-based compensation 1,918     1,918    
Performance - based common stock warrants 434     434    
Balance (in shares) at Mar. 31, 2019   24,019 (10,159)      
Balance at Mar. 31, 2019 265,172 $ 240 $ (277,104) 278,801 (18,548) 281,783
Balance (in shares) at Dec. 31, 2018   23,933 (10,116)      
Balance at Dec. 31, 2018 262,960 $ 239 $ (275,889) 276,103 (20,281) 282,788
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (3,397)          
Currency translation adjustment $ (5,557)          
Purchase of treasury shares (in shares) (55)          
Purchase of treasury shares $ (1,741)          
Stock options exercised (in shares) 20          
Balance (in shares) at Sep. 30, 2019   24,099 (10,171)      
Balance at Sep. 30, 2019 $ 261,651 $ 241 $ (277,630) 285,487 (25,838) 279,391
Balance (in shares) at Mar. 31, 2019   24,019 (10,159)      
Balance at Mar. 31, 2019 265,172 $ 240 $ (277,104) 278,801 (18,548) 281,783
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (5,061)         (5,061)
Currency translation adjustment (1,833)       (1,833)  
Shares issued for employee benefit plan and compensation (in shares)   17        
Shares issued for employee benefit plan and compensation 273 $ 0   273    
Purchase of treasury shares (in shares)     (5)      
Purchase of treasury shares (189)   $ (189)      
Shares issued to directors (in shares)   7        
Shares issued to directors 0 $ 0   0    
Employee and director stock-based compensation 2,273     2,273    
Performance - based common stock warrants 236     236    
Balance (in shares) at Jun. 30, 2019   24,043 (10,164)      
Balance at Jun. 30, 2019 260,871 $ 240 $ (277,293) 281,583 (20,381) 276,722
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 2,669         2,669
Currency translation adjustment (5,457)       (5,457)  
Shares issued for employee benefit plan and compensation (in shares)   29        
Shares issued for employee benefit plan and compensation 256 $ 1   255    
Purchase of treasury shares (in shares)     (7)      
Purchase of treasury shares (337)   $ (337)      
Stock options exercised (in shares)   20        
Stock options exercised 411     411    
Shares issued to directors (in shares)   7        
Shares issued to directors 0 $ 0   0    
Employee and director stock-based compensation 2,527     2,527    
Performance - based common stock warrants 711     711    
Balance (in shares) at Sep. 30, 2019   24,099 (10,171)      
Balance at Sep. 30, 2019 $ 261,651 $ 241 $ (277,630) $ 285,487 $ (25,838) $ 279,391